berberine has been researched along with Cancer of Ovary in 11 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of this study is to analyze the impact of berberine on the two human epithelial ovarian carcinoma cell lines OVCAR-3 and SKOV-3 in relation to the potential usefulness of berberine in the treatment of epithelial ovarian cancer." | 3.78 | Berberine-induced growth inhibition of epithelial ovarian carcinoma cell lines. ( Bae, J; Kim, JB; Lee, SJ; Park, KS, 2012) |
| "Berberine is an effective component extracted from the rhizomes of coptis chinensis and phellodendron chinensis." | 1.62 | Berberine inhibited metastasis through miR-145/MMP16 axis in vitro. ( Jiang, Y; Li, J; Pei, M; Wu, L; Zhang, S, 2021) |
| "Berberine is an extract of a traditional Chinese herbal medicine and has been shown to inhibit the proliferation and induce apoptosis in a wide variety of tumour cells." | 1.42 | Berberine exhibits antitumor effects in human ovarian cancer cells. ( Jin, P; Li, N; Zhang, C, 2015) |
| "Berberine could inhibit miR-21 expression and function in ovarian cancer, as shown by an enhancement of its target PDCD4, an important tumor suppressor in ovarian cancer." | 1.39 | Berberine sensitizes ovarian cancer cells to cisplatin through miR-21/PDCD4 axis. ( Fang, Y; Li, H; Liu, S; Shen, H; Xu, W, 2013) |
| "Berberine is a natural isoquinoline alkaloid with significant antitumor activity against many types of cancer cells, including ovarian tumors." | 1.39 | Modulation of the expression of folate cycle enzymes and polyamine metabolism by berberine in cisplatin-sensitive and -resistant human ovarian cancer cells. ( Costi, MP; Ferrari, S; Frassineti, C; Ligabue, A; Lombardi, P; Marverti, G; Monti, MG, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 7 (63.64) | 24.3611 |
| 2020's | 3 (27.27) | 2.80 |
| Authors | Studies |
|---|---|
| Chuang, TC | 1 |
| Wu, K | 1 |
| Lin, YY | 1 |
| Kuo, HP | 1 |
| Kao, MC | 1 |
| Wang, V | 1 |
| Hsu, SC | 1 |
| Lee, SL | 1 |
| Li, J | 2 |
| Zhang, S | 1 |
| Wu, L | 1 |
| Pei, M | 1 |
| Jiang, Y | 1 |
| Zhao, Y | 2 |
| Yang, X | 1 |
| Zhao, J | 1 |
| Gao, M | 1 |
| Zhang, M | 1 |
| Shi, T | 1 |
| Zhang, F | 2 |
| Zheng, X | 2 |
| Pan, Y | 2 |
| Shao, D | 2 |
| He, K | 2 |
| Chen, L | 2 |
| Hou, D | 1 |
| Xu, G | 1 |
| Zhang, C | 2 |
| Li, B | 1 |
| Qin, J | 1 |
| Hao, X | 1 |
| Liu, Q | 1 |
| Zhang, X | 1 |
| Liu, J | 2 |
| Wei, J | 1 |
| Gong, Y | 1 |
| Liu, Z | 1 |
| Shao, C | 1 |
| Cui, L | 1 |
| Zhang, H | 1 |
| Liu, L | 1 |
| Fan, J | 1 |
| Ai, G | 1 |
| Luo, N | 1 |
| Li, C | 1 |
| Cheng, Z | 1 |
| Liu, S | 1 |
| Fang, Y | 1 |
| Shen, H | 1 |
| Xu, W | 1 |
| Li, H | 1 |
| Marverti, G | 1 |
| Ligabue, A | 1 |
| Lombardi, P | 1 |
| Ferrari, S | 1 |
| Monti, MG | 1 |
| Frassineti, C | 1 |
| Costi, MP | 1 |
| Jin, P | 1 |
| Li, N | 1 |
| Park, KS | 1 |
| Kim, JB | 1 |
| Lee, SJ | 1 |
| Bae, J | 1 |
| Iwasa, K | 1 |
| Moriyasu, M | 1 |
| Yamori, T | 1 |
| Turuo, T | 1 |
| Lee, DU | 1 |
| Wiegrebe, W | 1 |
11 other studies available for berberine and Cancer of Ovary
| Article | Year |
|---|---|
Dual down-regulation of EGFR and ErbB2 by berberine contributes to suppression of migration and invasion of human ovarian cancer cells.
Topics: Berberine; Cell Line, Tumor; Down-Regulation; ErbB Receptors; Female; Humans; Ovarian Neoplasms; Pho | 2021 |
Berberine inhibited metastasis through miR-145/MMP16 axis in vitro.
Topics: Berberine; Cell Line, Tumor; Female; Humans; Matrix Metalloproteinase 16; MicroRNAs; Neoplasm Metast | 2021 |
Berberine inhibits chemotherapy-exacerbated ovarian cancer stem cell-like characteristics and metastasis through GLI1.
Topics: Antineoplastic Agents; Berberine; Carboplatin; Cell Line, Tumor; Cell Movement; Coculture Techniques | 2021 |
Berberine induces oxidative DNA damage and impairs homologous recombination repair in ovarian cancer cells to confer increased sensitivity to PARP inhibition.
Topics: Apoptosis; Berberine; Cell Line, Tumor; DNA Damage; Female; Humans; Ovarian Neoplasms; Oxidative Str | 2017 |
Berberine inhibits the chemotherapy-induced repopulation by suppressing the arachidonic acid metabolic pathway and phosphorylation of FAK in ovarian cancer.
Topics: Apoptosis; Arachidonic Acid; Berberine; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Prolif | 2017 |
Berberine in combination with cisplatin induces necroptosis and apoptosis in ovarian cancer cells.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Berberine; Caspase | 2019 |
Berberine sensitizes ovarian cancer cells to cisplatin through miR-21/PDCD4 axis.
Topics: 3' Untranslated Regions; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Berberine; | 2013 |
Modulation of the expression of folate cycle enzymes and polyamine metabolism by berberine in cisplatin-sensitive and -resistant human ovarian cancer cells.
Topics: Acetyltransferases; Berberine; Cell Line, Tumor; Cell Proliferation; Cisplatin; Drug Resistance, Neo | 2013 |
Berberine exhibits antitumor effects in human ovarian cancer cells.
Topics: Adaptor Proteins, Signal Transducing; Antineoplastic Agents; Apoptosis; Berberine; Cell Line, Tumor; | 2015 |
Berberine-induced growth inhibition of epithelial ovarian carcinoma cell lines.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Berberine; Carcinoma, Ovarian Epithelial; Cell Cycle; | 2012 |
In vitro cytotoxicity of the protoberberine-type alkaloids.
Topics: Animals; Antineoplastic Agents, Phytogenic; Berberine; Berberine Alkaloids; Brain Neoplasms; Breast | 2001 |